California ICE Detention Center Found to Have Inadequate Medical Care, Court Monitor Says 
Meta Ordered to Pay $567M Over Child Safety Violations in New Mexico 
US Supreme Court Lets $655.5 Million Judgment Against Palestinian Authorities Stand During Appeal 
Hims & Hers Shares Fall as GLP-1 Costs Widen Q2 Loss 
Takeda Hit With $885M Verdict Over Amitiza Generic Drug Delay Scheme 
DOJ Subpoenas New York Times Freelancer Over North Korea Military Report 
Novo Nordisk Eyes Turnaround as Oral Wegovy Challenges Eli Lilly in Weight-Loss Drug Race 
Moderna Wins FDA Approval for mFLUSIVA mRNA Flu Vaccine for Adults 50+ 
EEOC Drops Penn Subpoena in Antisemitism Probe, Investigation Continues 
Berkshire Hathaway Cash Falls as Abel Boosts Stock Buybacks 
Anthropic Signs $9.1B AI Data Center Deal With Riot Platforms 
GSK Reportedly Nears $9 Billion Acquisition of Cancer Drug Developer Nuvalent 
AstraZeneca Shares Sink After Wainua Trial Misses Key Heart Disease Goal 
Domino’s Weighs Appeal After Australian Court Rules Workers Were Misled on Pay 
Trump Election Order Blocked Again as Appeals Court Rejects Mail-In Voting Push in 23 States 
Nvidia Seen Beating Q2 Targets as Vera Rubin Cycle Begins 
Paramount-Warner Bros. Merger Delayed Until 2027 Amid Antitrust Lawsuit 
On Monday, a U.S. appeals court ruled in favor of 3M, E.I. du Pont de Nemours and Co, and other manufacturers of "forever chemicals." The court rejected a lower court's ruling, allowing approximately 11.8 million Ohio residents to sue the companies.
Reuters noted that the ruling relieves considerable legal pressure placed on the chemical manufacturers to settle the plaintiffs' claims.
Court Ruling Questions Class Action Suit's Validity
According to Yahoo, Lead plaintiff Kevin Hardwick's complaint against the manufacturers faced scrutiny from the court. The appeals court found his complaint to be overly broad and lacking evidence that the per- and polyfluoroalkyl substances (PFAS) detected in his body could be directly attributed to the defendants.
The court emphasized that the complaint targeted the collective actions of the companies rather than individual responsibility. Notably, the case involved just 10 out of thousands of companies involved in PFAS manufacturing.
The lower court's approval of the class action suit has been vacated, and the court instructed the dismissal of Hardwick's lawsuit. The lawsuit aimed to hold the companies accountable for the health impacts of PFAS exposure and sought to establish a fund to monitor Ohio residents.
Additionally, Hardwick's request for the companies to fund studies on the health effects of PFAS was denied. These forever chemicals, commonly found in consumer products, have been linked to cancer and other diseases.
Robert Bilott, attorney for Hardwick, expressed disappointment with the court's decision. He stated that it contradicts what is known about the history of PFAS manufacturing in the United States. Bilott's legal team is currently evaluating whether to appeal the ruling further.
The Persistence and Prevalence of Forever Chemicals
PFAS substances earned the nickname "forever chemicals" due to their resistance to breaking down in nature or in the human body. The growing number of lawsuits filed against 3M, DuPont, and other manufacturers in recent years reflect concerns over alleged PFAS contamination.
In June, 3M agreed to pay $10.3 billion to settle hundreds of claims regarding public drinking water pollution caused by PFAS. Furthermore, Chemours Co, DuPont de Nemours Inc, and Corteva reached a similar settlement worth $1.19 billion with U.S. water providers.
Photo: 3M News Center
